Viewing Study NCT06455202


Ignite Creation Date: 2025-12-25 @ 3:54 AM
Ignite Modification Date: 2025-12-26 @ 2:44 AM
Study NCT ID: NCT06455202
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2024-06-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Sponsor: Celldex Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module